Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivimed Labs

BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01021|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Mar 27, 16:00
96.25
-0.9 (-0.93%)
VOLUME 42,288
LIVE
NSE
Mar 27, 15:57
96.35
-0.55 (-0.57%)
VOLUME 206,326
Announcements on Vivimed Labs

14th-Mar-2017 10:21Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has submitted the Exchange a copy Scrutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

13th-Mar-2017 16:05Source: BSE

Vivimed Labs- Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Vivimed Labs Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer''s Report.

20th-Feb-2017 12:06Source: BSE

Vivimed Labs- Limited Review Report for December 31, 2016

Vivimed Labs Ltd has informed BSE about :

1. Consolidated Limited Review for the period ended December 31, 2016

15th-Feb-2017 08:53Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on February 14, 2017.

14th-Feb-2017 20:21Source: BSE

Vivimed Labs- Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016

Vivimed Labs Ltd has informed BSE about :

1. Standalone Financial Results for the period ended December 31, 2016

2. Consolidated Financial Results for the period ended December 31, 2016...

7th-Feb-2017 18:06Source: BSE

Vivimed Labs- Notice of Postal Ballot

Vivimed Labs Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.

31st-Jan-2017 18:01Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandeep Varalwar

30th-Jan-2017 14:21Source: BSE

Vivimed Labs- Board Meeting Intimation for Results & Closure of Trading Window

Vivimed Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 14, 2017, inter alia, to consider and approve the unaudited Financial Results of the ...

27th-Jan-2017 16:39Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011`

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manohar Rao Varalwar

24th-Jan-2017 11:24Source: NSE

Vivimed Labs Limited

VIVIMEDLAB: The Exchange had sought clarification from Vivimed Labs Limited with respect to announcement dated 12-Jan-2017, regarding Outcome of Board Meeting held on January 12, 2017.On basis of abov...

1 2 3 4 5 Next >>
Quick Links for Vivimed Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.